US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Park Hotels & Resorts Inc.

10.60

+0.19001.83%

Post-market: 10.600.00000.00%18:06 EDT

Volume:3.07M

Turnover:32.54M

Market Cap:2.13B

PE:-7.41

High:10.68

Open:10.54

Low:10.46

Close:10.41

52wk High:12.39

52wk Low:8.27

Shares:201.40M

Float Shares:195.63M

Volume Ratio:0.93

T/O Rate:1.57%

Dividend:1.00

Dividend Rate:9.43%

EPS(TTM):-1.4300

EPS(LYR):-1.4300

ROE:-8.31%

ROA:2.12%

PB:0.68

PE(LYR):-7.41

Loading ...

Overview Company News Filings

Press Release: Gain Therapeutics Reports Financial Results for Third Quarter 2025 and Provides Corporate Update

EirGenix Signed The Commercial Licensinse Agreement for It's Second HER2 Biosimilar Asset EG1206A

Shield Therapeutics to Present Pediatric PK Results at ASH Conference

Annexon Reports Third Quarter 2025 Financial Results, Portfolio Progress and Key Anticipated Milestones

Immunocore presents Phase 1 data for hepatitis B candidate at AASLD’s The Liver Meeting

Press Release: Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2025

Erasca Announces Issuance of a U.S. Patent Covering Pan-RAS Molecular Glue ERAS-0015

Press Release: Sionna Therapeutics Reports Third Quarter 2025 Financial Results

Centessa Pharmaceuticals Reports Financial Results for the Third Quarter of 2025 and Provides Update on Potential Best-in-Class Orexin Receptor 2 (OX2R) Agonist Program

Avadel Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Certara Automates Scientific Workflows with Phoenix® Cloud

Tonix Pharmaceuticals Announces Collaboration with Massachusetts General Hospital to Advance Phase 2 Clinical Trial of Dimeric Fc-modified anti-CD40L mAb, TNX-1500, to Prevent Kidney Transplant Organ Rejection

ProMIS Neurosciences to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference

B. Riley Adjusts Price Target on PK International to $16 From $12.50, Maintains Buy Rating

MT Newswires Live

Agios to Present New Mitapivat Data in Rare Blood Disorders at 67th ASH Annual Meeting and Exposition

Which App is Best for Tracking Gold Prices? Ultimate Comparison of Three Platforms – This One is Favored by Gold Investors!

Evercore ISI Keeps Their Hold Rating on Park Hotels & Resorts (PK)

Park Hotels & Resorts Inc reports results for the quarter ended September 30 - Earnings Summary

Park Hotels & Resorts posts $14 million net loss in Q3 2025

BRIEF-Park Hotels & Resorts Q3 Adjusted FFO Per Share USD 0.35

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PK/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"PK","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PK\",,,,,undefined,":{"symbol":"PK","market":"US","secType":"STK","nameCN":"Park Hotels & Resorts Inc.","latestPrice":10.6,"timestamp":1774468800000,"preClose":10.41,"halted":0,"volume":3071248,"hourTrading":{"tag":"盘后","latestPrice":10.6,"preClose":10.6,"latestTime":"18:06 EDT","volume":249171,"amount":2641213.66,"timestamp":1774476401605,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.01825168107588852,"floatShares":195633448,"shares":201398439,"eps":-1.43,"marketStatus":"Not Yet Opened","change":0.19,"latestTime":"03-25 16:00:00 EDT","open":10.54,"high":10.675,"low":10.455,"amount":32543763.831215996,"amplitude":0.021134,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.43,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774512000000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":10.41,"dividendRate":0.09434,"preHourTrading":{"tag":"盘前","latestPrice":10.51,"preClose":10.41,"latestTime":"08:03 EDT","volume":892,"amount":9591.029299999998,"timestamp":1774440202270,"change":0.1,"changeRate":0.009606,"amplitude":0.036177},"postHourTrading":{"tag":"盘后","latestPrice":10.6,"preClose":10.6,"latestTime":"18:06 EDT","volume":249171,"amount":2641213.66,"timestamp":1774476401605,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.927974,"impliedVol":0.3343,"impliedVolPercentile":0.259},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PK\",,,,,undefined,":{"symbol":"PK","floatShares":195633448,"roa":"2.12%","roe":"-8.31%","lyrEps":-1.43,"volumeRatio":0.927974,"shares":201398439,"dividePrice":1,"high":10.675,"amplitude":0.021134,"preClose":10.41,"low":10.455,"week52Low":8.27,"pbRate":"0.68","psRate":"0.84","week52High":12.39,"institutionHeld":0,"latestPrice":10.6,"eps":-1.43,"divideRate":0.09434,"volume":3071248,"delay":0,"ttmEps":-1.43,"open":10.54,"prevYearClose":10.46,"prevWeekClose":10.27,"prevMonthClose":11.31,"prevQuarterClose":10.46,"fiveDayClose":10.51,"twentyDayClose":11.26,"sixtyDayClose":10.84,"dividendPayoutRate":1.373460620431404,"dividendFrequency":"Q","dividendGrowthYears":0,"dividendGrowthRate":-0.28571428571428564,"fiveYearAvgDividendRate":0.07559574201047665},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PK\",params:#limit:5,,,undefined,":[{"date":"2026-04-30","symbol":"PK","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2026/03","expectedEps":0.41,"defaultRemindTime":1777579200000,"name":null,"time":"Post Market","dateTimestamp":1777521600000,"actualEps":null},{"date":"2026-03-31","symbol":"PK","amount":0.25,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-31","defaultRemindTime":1774963800000,"name":"Park Hotels & Resorts Inc.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-04-15","payableDate":"2026-03-31","currency":"USD","dateTimestamp":1774929600000,"payDate":"2026-04-15"},{"date":"2026-02-19","symbol":"PK","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/12","expectedEps":0.44,"defaultRemindTime":1771534800000,"name":null,"time":"Post Market","dateTimestamp":1771477200000,"actualEps":null},{"date":"2025-12-31","symbol":"PK","amount":0.25,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-31","defaultRemindTime":1767191400000,"name":"Park Hotels & Resorts Inc.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-15","payableDate":"2025-12-31","currency":"USD","dateTimestamp":1767157200000,"payDate":"2026-01-15"},{"date":"2025-10-30","symbol":"PK","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/09","expectedEps":0.42,"defaultRemindTime":1761854400000,"name":null,"time":"Post Market","dateTimestamp":1761796800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PK\",market:\"US\",,,undefined,":[{"executeDate":"2017-03-29","recordDate":"2017-03-31","paymentDate":"2017-04-17","value":0.43,"currency":"USD"},{"executeDate":"2017-06-28","recordDate":"2017-06-30","paymentDate":"2017-07-17","value":0.43,"currency":"USD"},{"executeDate":"2017-09-28","recordDate":"2017-09-29","paymentDate":"2017-10-16","value":0.43,"currency":"USD"},{"executeDate":"2017-12-28","recordDate":"2017-12-29","paymentDate":"2018-01-16","value":0.55,"currency":"USD"},{"executeDate":"2018-03-28","recordDate":"2018-03-30","paymentDate":"2018-04-16","value":0.43,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PK\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.0588,"buy":0.1176,"hold":0.7059,"sell":0.1176,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.7059,"analysts":17,"updateTime":1767758400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PK\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PK","date":"2026-03-24","current":-7.412587,"percent":0.347039,"low":-196.066894,"twenty":-46.332575,"median":-3.597855,"eighty":17.810878,"high":55.399897,"avg":-10.714997,"sd":52.687635,"marketCap":2101118977},"quantilePoints":[{"date":"2021-03-26","current":-3.589648,"twenty":-2.723118,"median":13.200933,"eighty":29.409492,"marketCap":5169093647},{"date":"2021-04-01","current":-3.581442,"twenty":-2.747858,"median":13.188305,"eighty":29.387036,"marketCap":5157275875},{"date":"2021-04-09","current":-3.522353,"twenty":-2.785256,"median":13.150762,"eighty":29.281497,"marketCap":5072187914},{"date":"2021-04-16","current":-3.497732,"twenty":-2.84164,"median":13.078426,"eighty":29.200659,"marketCap":5036734596},{"date":"2021-04-23","current":-3.597855,"twenty":-2.856599,"median":13.071715,"eighty":29.043473,"marketCap":5180911420},{"date":"2021-04-30","current":-3.661868,"twenty":-2.86063,"median":13.065856,"eighty":28.92446,"marketCap":5273090044},{"date":"2021-05-07","current":-5.611001,"twenty":-2.872133,"median":13.00038,"eighty":27.600316,"marketCap":5285562943},{"date":"2021-05-14","current":-5.538196,"twenty":-2.918736,"median":12.98625,"eighty":26.702293,"marketCap":5216980694},{"date":"2021-05-21","current":-5.07124,"twenty":-2.973394,"median":12.984113,"eighty":26.504319,"marketCap":4777108342},{"date":"2021-05-28","current":-5.219361,"twenty":-3.010216,"median":12.953043,"eighty":26.370989,"marketCap":4916637744},{"date":"2021-06-04","current":-5.151577,"twenty":-3.032655,"median":12.935438,"eighty":26.342707,"marketCap":4852785306},{"date":"2021-06-11","current":-5.407649,"twenty":-3.066646,"median":12.921003,"eighty":26.23968,"marketCap":5094005628},{"date":"2021-06-18","current":-5.181703,"twenty":-3.103007,"median":12.910479,"eighty":26.122512,"marketCap":4881164167},{"date":"2021-06-25","current":-5.407649,"twenty":-3.130464,"median":12.883118,"eighty":26.110391,"marketCap":5094005628},{"date":"2021-07-02","current":-5.103877,"twenty":-3.201231,"median":12.837305,"eighty":26.041706,"marketCap":4807852108},{"date":"2021-07-09","current":-4.933162,"twenty":-3.220989,"median":12.808486,"eighty":25.863933,"marketCap":4647038560},{"date":"2021-07-16","current":-4.616837,"twenty":-3.39668,"median":12.795175,"eighty":25.55283,"marketCap":4349060515},{"date":"2021-07-23","current":-4.684621,"twenty":-3.442298,"median":12.778454,"eighty":25.461924,"marketCap":4412912953},{"date":"2021-07-30","current":-4.644453,"twenty":-3.472857,"median":12.762007,"eighty":25.27203,"marketCap":4375074472},{"date":"2021-08-06","current":-5.555659,"twenty":-3.499046,"median":12.754728,"eighty":25.175063,"marketCap":4438971639},{"date":"2021-08-13","current":-5.472783,"twenty":-3.515459,"median":12.739067,"eighty":25.092237,"marketCap":4372753628},{"date":"2021-08-20","current":-5.209355,"twenty":-3.540249,"median":12.712634,"eighty":25.013451,"marketCap":4162274952},{"date":"2021-08-27","current":-5.74509,"twenty":-3.546559,"median":12.705805,"eighty":24.987189,"marketCap":4590327091},{"date":"2021-09-03","current":-5.52902,"twenty":-3.565932,"median":12.702277,"eighty":24.944766,"marketCap":4417687278},{"date":"2021-09-10","current":-5.437265,"twenty":-3.571599,"median":12.695796,"eighty":24.807396,"marketCap":4344374481},{"date":"2021-09-17","current":-5.688853,"twenty":-3.581314,"median":12.675381,"eighty":24.746792,"marketCap":4545393441},{"date":"2021-09-24","current":-5.97004,"twenty":-3.589648,"median":12.636863,"eighty":24.72659,"marketCap":4770061692},{"date":"2021-10-01","current":-5.896043,"twenty":-3.599497,"median":12.622139,"eighty":24.665986,"marketCap":4710938468},{"date":"2021-10-08","current":-5.721411,"twenty":-3.607845,"median":12.595518,"eighty":24.655885,"marketCap":4571407660},{"date":"2021-10-15","current":-5.659254,"twenty":-3.625758,"median":12.578404,"eighty":24.655885,"marketCap":4521744152},{"date":"2021-10-22","current":-5.505341,"twenty":-3.649856,"median":12.569511,"eighty":24.645785,"marketCap":4398767847},{"date":"2021-10-29","current":-5.484622,"twenty":-3.670075,"median":12.545167,"eighty":24.625583,"marketCap":4382213344},{"date":"2021-11-05","current":-8.201051,"twenty":-3.681985,"median":12.518997,"eighty":24.605382,"marketCap":4994440260},{"date":"2021-11-12","current":-7.56811,"twenty":-3.701263,"median":12.505104,"eighty":24.575079,"marketCap":4608979198},{"date":"2021-11-19","current":-7.339009,"twenty":-3.720957,"median":12.481428,"eighty":24.44377,"marketCap":4469456483},{"date":"2021-11-26","current":-6.989532,"twenty":-3.729965,"median":12.465978,"eighty":24.427609,"marketCap":4256625222},{"date":"2021-12-03","current":-6.488616,"twenty":-3.750955,"median":12.411262,"eighty":24.415488,"marketCap":3951567081},{"date":"2021-12-10","current":-7.129323,"twenty":-3.770233,"median":12.390156,"eighty":24.397368,"marketCap":4341757726},{"date":"2021-12-17","current":-6.752665,"twenty":-3.792938,"median":12.369502,"eighty":24.247831,"marketCap":4112372922},{"date":"2021-12-23","current":-7.490449,"twenty":-3.83227,"median":12.348324,"eighty":24.162969,"marketCap":4561683362},{"date":"2021-12-31","current":-7.331243,"twenty":-3.873903,"median":12.336915,"eighty":24.124587,"marketCap":4464726899},{"date":"2022-01-07","current":-7.692369,"twenty":-3.888468,"median":12.314228,"eighty":24.072063,"marketCap":4684652535},{"date":"2022-01-14","current":-7.548695,"twenty":-3.917478,"median":12.283673,"eighty":24.03368,"marketCap":4597155239},{"date":"2022-01-21","current":-7.032246,"twenty":-3.996222,"median":12.241172,"eighty":24.02964,"marketCap":4282637931},{"date":"2022-01-28","current":-6.803145,"twenty":-4.087905,"median":12.214275,"eighty":24.013479,"marketCap":4143115216},{"date":"2022-02-04","current":-7.051662,"twenty":-4.210886,"median":12.177189,"eighty":23.964995,"marketCap":4294461890},{"date":"2022-02-11","current":-7.339009,"twenty":-4.305038,"median":12.115818,"eighty":23.924593,"marketCap":4469456483},{"date":"2022-02-18","current":-9.97933,"twenty":-4.379327,"median":12.077002,"eighty":23.906411,"marketCap":4580512556},{"date":"2022-02-25","current":-9.762948,"twenty":-4.434604,"median":12.034907,"eighty":23.88419,"marketCap":4481193234},{"date":"2022-03-04","current":-9.294121,"twenty":-4.477502,"median":11.989722,"eighty":23.857928,"marketCap":4266001369},{"date":"2022-03-11","current":-9.515655,"twenty":-4.530065,"median":11.874947,"eighty":23.585208,"marketCap":4367685437},{"date":"2022-03-18","current":-9.793479,"twenty":-4.62021,"median":11.802039,"eighty":23.304408,"marketCap":4495206674},{"date":"2022-03-25","current":-9.839796,"twenty":-4.668569,"median":11.613959,"eighty":23.136735,"marketCap":4516466191},{"date":"2022-04-01","current":-10.045649,"twenty":-4.723283,"median":11.244693,"eighty":22.801391,"marketCap":4610952931},{"date":"2022-04-08","current":-8.795089,"twenty":-4.748358,"median":11.177001,"eighty":22.577155,"marketCap":4036945983},{"date":"2022-04-14","current":-9.860381,"twenty":-4.774334,"median":11.132722,"eighty":22.280194,"marketCap":4525914865},{"date":"2022-04-22","current":-9.999332,"twenty":-4.831692,"median":11.002063,"eighty":21.938028,"marketCap":4589693414},{"date":"2022-04-29","current":-10.143429,"twenty":-4.933265,"median":10.846102,"eighty":20.988446,"marketCap":4655834133},{"date":"2022-05-06","current":-13.808923,"twenty":-5.010567,"median":10.72108,"eighty":20.329014,"marketCap":4501708843},{"date":"2022-05-13","current":-13.178967,"twenty":-5.093895,"median":7.386072,"eighty":20.146479,"marketCap":4296343172},{"date":"2022-05-20","current":-11.861786,"twenty":-5.147058,"median":6.828781,"eighty":19.994366,"marketCap":3866942225},{"date":"2022-05-27","current":-13.143174,"twenty":-5.175677,"median":6.45202,"eighty":19.781409,"marketCap":4284674668},{"date":"2022-06-03","current":-13.207601,"twenty":-5.20439,"median":6.373529,"eighty":19.661408,"marketCap":4305677976},{"date":"2022-06-10","current":-12.055068,"twenty":-5.217352,"median":6.1773,"eighty":18.57907,"marketCap":3929952147},{"date":"2022-06-17","current":-10.229627,"twenty":-5.287145,"median":5.839785,"eighty":18.013987,"marketCap":3334858443},{"date":"2022-06-24","current":-10.1652,"twenty":-5.323251,"median":5.651405,"eighty":17.603643,"marketCap":3313855136},{"date":"2022-07-01","current":-9.70705,"twenty":-5.360954,"median":5.101963,"eighty":17.208917,"marketCap":3164498284},{"date":"2022-07-08","current":-9.85738,"twenty":-5.388567,"median":3.861793,"eighty":17.068349,"marketCap":3213506001},{"date":"2022-07-15","current":-9.921808,"twenty":-5.409668,"median":2.45556,"eighty":16.809931,"marketCap":3234509308},{"date":"2022-07-22","current":-10.487336,"twenty":-5.439477,"median":2.417283,"eighty":16.594109,"marketCap":3418871672},{"date":"2022-07-29","current":-11.160244,"twenty":-5.472783,"median":2.404801,"eighty":15.354106,"marketCap":3638239547},{"date":"2022-08-05","current":-56.398031,"twenty":-5.505341,"median":2.387327,"eighty":15.148576,"marketCap":3383881882},{"date":"2022-08-12","current":-60.145409,"twenty":-5.52902,"median":2.299955,"eighty":15.006602,"marketCap":3608724532},{"date":"2022-08-19","current":-55.873399,"twenty":-5.552107,"median":2.257518,"eighty":14.887345,"marketCap":3352403911},{"date":"2022-08-26","current":-53.287708,"twenty":-5.563474,"median":2.212781,"eighty":14.845845,"marketCap":3197262483},{"date":"2022-09-02","current":-52.238442,"twenty":-5.614856,"median":2.207821,"eighty":14.818112,"marketCap":3134306541},{"date":"2022-09-09","current":-54.786659,"twenty":-5.644455,"median":2.197209,"eighty":14.800268,"marketCap":3287199543},{"date":"2022-09-16","current":-52.051073,"twenty":-5.663398,"median":2.187137,"eighty":14.752289,"marketCap":3123064408},{"date":"2022-09-23","current":-44.593792,"twenty":-5.688853,"median":2.168482,"eighty":14.705619,"marketCap":2675627535},{"date":"2022-09-30","current":-42.195471,"twenty":-5.714833,"median":2.125089,"eighty":14.651669,"marketCap":2531728239},{"date":"2022-10-07","current":-43.582,"twenty":-5.729107,"median":2.082185,"eighty":14.616649,"marketCap":2614920019},{"date":"2022-10-14","current":-44.219054,"twenty":-5.777649,"median":2.070313,"eighty":14.587307,"marketCap":2653143270},{"date":"2022-10-21","current":-47.216957,"twenty":-5.925642,"median":2.05882,"eighty":14.530184,"marketCap":2833017390},{"date":"2022-10-28","current":-48.828329,"twenty":-6.246611,"median":2.029326,"eighty":14.486979,"marketCap":2929699729},{"date":"2022-11-04","current":43.862859,"twenty":-6.452657,"median":2.015912,"eighty":14.434922,"marketCap":2675634425},{"date":"2022-11-11","current":47.03278,"twenty":-6.452657,"median":2.015912,"eighty":14.434922,"marketCap":2868999602},{"date":"2022-11-18","current":45.005505,"twenty":-6.452657,"median":2.015912,"eighty":14.434922,"marketCap":2745335826},{"date":"2022-11-25","current":45.742696,"twenty":-6.452657,"median":2.015912,"eighty":14.434922,"marketCap":2790304471},{"date":"2022-12-02","current":46.553606,"twenty":-6.452657,"median":2.015912,"eighty":14.434922,"marketCap":2839769982},{"date":"2022-12-09","current":45.41096,"twenty":-6.452657,"median":2.015912,"eighty":14.434922,"marketCap":2770068581},{"date":"2022-12-16","current":44.342034,"twenty":-6.452657,"median":2.015912,"eighty":14.434922,"marketCap":2704864044},{"date":"2022-12-23","current":42.941371,"twenty":-6.452657,"median":2.015912,"eighty":14.434922,"marketCap":2619423617},{"date":"2022-12-30","current":43.457404,"twenty":-6.452657,"median":2.015912,"eighty":14.434922,"marketCap":2650901669},{"date":"2023-01-06","current":44.010298,"twenty":-6.452657,"median":2.015912,"eighty":14.499284,"marketCap":2684628154},{"date":"2023-01-13","current":46.332449,"twenty":-6.452657,"median":2.015912,"eighty":14.544715,"marketCap":2826279388},{"date":"2023-01-20","current":47.585674,"twenty":-6.452657,"median":2.015912,"eighty":14.591155,"marketCap":2902726086},{"date":"2023-01-27","current":53.188324,"twenty":-6.452657,"median":2.015912,"eighty":14.629303,"marketCap":3244487794},{"date":"2023-02-03","current":54.478409,"twenty":-6.452657,"median":2.015912,"eighty":14.659241,"marketCap":3323182924},{"date":"2023-02-10","current":52.598572,"twenty":-6.452657,"median":2.015912,"eighty":14.710351,"marketCap":3208512877},{"date":"2023-02-17","current":50.681875,"twenty":-6.452657,"median":2.015912,"eighty":14.776825,"marketCap":3091594398},{"date":"2023-02-24","current":19.081678,"twenty":-6.452657,"median":2.015912,"eighty":14.800268,"marketCap":3091231855},{"date":"2023-03-03","current":19.2873,"twenty":-6.452657,"median":2.020509,"eighty":14.820409,"marketCap":3124542543},{"date":"2023-03-10","current":17.080295,"twenty":-6.452657,"median":2.020509,"eighty":14.858004,"marketCap":2767007824},{"date":"2023-03-17","current":15.80726,"twenty":-6.452657,"median":2.020509,"eighty":14.898703,"marketCap":2560776060},{"date":"2023-03-24","current":15.423721,"twenty":-6.452657,"median":2.034301,"eighty":15.020423,"marketCap":2498642845},{"date":"2023-03-31","current":16.930479,"twenty":-6.449731,"median":2.061884,"eighty":15.148576,"marketCap":2742737617},{"date":"2023-04-06","current":16.355172,"twenty":-6.449731,"median":2.08027,"eighty":15.339767,"marketCap":2649537795},{"date":"2023-04-14","current":16.231891,"twenty":-6.452657,"median":2.187137,"eighty":15.656584,"marketCap":2629566405},{"date":"2023-04-21","current":16.1771,"twenty":-6.452657,"median":2.20399,"eighty":16.160663,"marketCap":2620690231},{"date":"2023-04-28","current":15.916842,"twenty":-6.452657,"median":3.861793,"eighty":16.193538,"marketCap":2578528407},{"date":"2023-05-05","current":10.781494,"twenty":-6.452657,"median":4.795845,"eighty":16.193538,"marketCap":2716936387},{"date":"2023-05-12","current":11.431806,"twenty":-6.452657,"median":4.795845,"eighty":16.193538,"marketCap":2880815089},{"date":"2023-05-19","current":11.705622,"twenty":-6.452657,"median":4.795845,"eighty":16.193538,"marketCap":2949816648},{"date":"2023-05-26","current":11.13232,"twenty":-6.452657,"median":4.795845,"eighty":16.193538,"marketCap":2805344634},{"date":"2023-06-02","current":11.115206,"twenty":-6.452657,"median":4.795845,"eighty":16.193538,"marketCap":2801032037},{"date":"2023-06-09","current":12.184799,"twenty":-6.452657,"median":4.795845,"eighty":16.193538,"marketCap":3070569377},{"date":"2023-06-16","current":11.243558,"twenty":-6.452657,"median":4.795845,"eighty":16.193538,"marketCap":2833376518},{"date":"2023-06-23","current":10.71304,"twenty":-6.455582,"median":4.787996,"eighty":16.201756,"marketCap":2699685997},{"date":"2023-06-30","current":10.926958,"twenty":-6.458508,"median":4.780147,"eighty":16.209975,"marketCap":2753593465},{"date":"2023-07-07","current":11.226444,"twenty":-6.458508,"median":4.780147,"eighty":16.209975,"marketCap":2829063920},{"date":"2023-07-14","current":11.799746,"twenty":-6.458508,"median":4.780147,"eighty":16.209975,"marketCap":2973535934},{"date":"2023-07-21","current":11.260671,"twenty":-6.458508,"median":4.780147,"eighty":16.209975,"marketCap":2837689115},{"date":"2023-07-28","current":10.76438,"twenty":-6.458508,"median":4.780147,"eighty":16.209975,"marketCap":2712623789},{"date":"2023-08-04","current":-57.485197,"twenty":-6.501042,"median":3.861793,"eighty":16.209975,"marketCap":2759289480},{"date":"2023-08-11","current":-60.090736,"twenty":-6.750335,"median":-2.450979,"eighty":16.209975,"marketCap":2884355344},{"date":"2023-08-18","current":-56.854736,"twenty":-6.930509,"median":-2.566048,"eighty":16.209975,"marketCap":2729027307},{"date":"2023-08-25","current":-56.854736,"twenty":-7.00324,"median":-2.678241,"eighty":16.209975,"marketCap":2729027307},{"date":"2023-08-31","current":-58.203069,"twenty":-7.047778,"median":-2.730022,"eighty":16.209975,"marketCap":2793747322},{"date":"2023-09-08","current":-56.225513,"twenty":-7.135536,"median":-2.76742,"eighty":16.220933,"marketCap":2698824633},{"date":"2023-09-13","current":-59.641292,"twenty":-7.238826,"median":-2.81236,"eighty":16.220933,"marketCap":2862782005},{"date":"2023-09-20","current":-56.49518,"twenty":-7.292412,"median":-2.856599,"eighty":16.226412,"marketCap":2711768636},{"date":"2023-09-29","current":-56.270458,"twenty":-7.33179,"median":-2.859478,"eighty":16.256547,"marketCap":2700981967},{"date":"2023-10-06","current":-54.068179,"twenty":-7.350658,"median":-2.872421,"eighty":16.256547,"marketCap":2595272609},{"date":"2023-10-13","current":-54.023235,"twenty":-7.41434,"median":-2.928517,"eighty":16.256547,"marketCap":2593115275},{"date":"2023-10-20","current":-52.944568,"twenty":-7.474917,"median":-3.004751,"eighty":16.256547,"marketCap":2541339263},{"date":"2023-10-23","current":-52.405235,"twenty":-7.491226,"median":-3.007627,"eighty":16.256547,"marketCap":2515451257},{"date":"2023-11-03","current":-48.333767,"twenty":-7.537046,"median":-3.046463,"eighty":16.355172,"marketCap":2706690937},{"date":"2023-11-10","current":-48.821216,"twenty":-7.614707,"median":-3.102759,"eighty":16.355172,"marketCap":2733988086},{"date":"2023-11-17","current":-52.758411,"twenty":-7.692369,"median":-3.147149,"eighty":16.355172,"marketCap":2954470996},{"date":"2023-11-24","current":-54.558271,"twenty":-8.07291,"median":-3.21274,"eighty":16.355172,"marketCap":3055263184},{"date":"2023-12-01","current":-55.60819,"twenty":-8.887723,"median":-3.353198,"eighty":16.355172,"marketCap":3114058626},{"date":"2023-12-08","current":-56.170646,"twenty":-9.20165,"median":-3.416563,"eighty":16.355172,"marketCap":3145556185},{"date":"2023-12-13","current":-57.820518,"twenty":-9.294121,"median":-3.460856,"eighty":16.355172,"marketCap":3237949024},{"date":"2023-12-22","current":-62.432661,"twenty":-9.507389,"median":-3.497732,"eighty":16.36339,"marketCap":3496229004},{"date":"2024-01-05","current":-59.020425,"twenty":-9.574387,"median":-3.519891,"eighty":16.393525,"marketCap":3305143815},{"date":"2024-01-12","current":-60.445315,"twenty":-9.664756,"median":-3.542049,"eighty":16.393525,"marketCap":3384937630},{"date":"2024-01-19","current":-59.99535,"twenty":-9.712777,"median":-3.553469,"eighty":16.401744,"marketCap":3359739584},{"date":"2024-01-26","current":-58.232986,"twenty":-9.763771,"median":-3.571596,"eighty":16.393525,"marketCap":3261047233},{"date":"2024-02-02","current":-66.888565,"twenty":-9.823019,"median":-3.581378,"eighty":16.393525,"marketCap":3210651139},{"date":"2024-02-09","current":-57.220565,"twenty":-9.869644,"median":-3.59147,"eighty":16.393525,"marketCap":3204351628},{"date":"2024-02-16","current":-57.220565,"twenty":-9.956321,"median":-3.604489,"eighty":16.393525,"marketCap":3204351628},{"date":"2024-02-23","current":-60.89528,"twenty":-10.043591,"median":-3.622011,"eighty":16.393525,"marketCap":3410135677},{"date":"2024-03-01","current":35.936019,"twenty":-10.056469,"median":-3.625758,"eighty":16.447807,"marketCap":3485793844},{"date":"2024-03-08","current":37.18843,"twenty":-10.056469,"median":-3.625758,"eighty":16.567212,"marketCap":3607277745},{"date":"2024-03-15","current":36.961243,"twenty":-10.056469,"median":-3.625758,"eighty":16.670221,"marketCap":3585240545},{"date":"2024-03-22","current":38.523902,"twenty":-10.056469,"median":-3.625758,"eighty":16.766106,"marketCap":3736818537},{"date":"2024-03-28","current":38.306866,"twenty":-10.056469,"median":-3.625758,"eighty":16.809931,"marketCap":3715766038},{"date":"2024-04-05","current":37.156575,"twenty":-10.059306,"median":-3.629041,"eighty":16.978896,"marketCap":3604187794},{"date":"2024-04-12","current":37.894498,"twenty":-10.059306,"median":-3.629041,"eighty":17.16064,"marketCap":3675766290},{"date":"2024-04-19","current":35.007918,"twenty":-10.059306,"median":-3.629041,"eighty":17.258612,"marketCap":3395768056},{"date":"2024-04-26","current":35.44199,"twenty":-10.056469,"median":-3.625758,"eighty":17.840762,"marketCap":3437873054},{"date":"2024-05-03","current":36.498796,"twenty":-10.056469,"median":-3.625758,"eighty":18.170174,"marketCap":3357889189},{"date":"2024-05-10","current":36.511207,"twenty":-10.056469,"median":-3.625758,"eighty":18.755351,"marketCap":3359031034},{"date":"2024-05-17","current":37.541304,"twenty":-10.056469,"median":-3.625758,"eighty":19.13678,"marketCap":3453799934},{"date":"2024-05-24","current":36.396752,"twenty":-10.056469,"median":-3.625758,"eighty":19.228198,"marketCap":3348501156},{"date":"2024-05-31","current":35.595565,"twenty":-10.056469,"median":-3.625758,"eighty":19.551549,"marketCap":3274792011},{"date":"2024-06-07","current":34.863052,"twenty":-10.056469,"median":-3.625758,"eighty":19.788169,"marketCap":3207400793},{"date":"2024-06-14","current":34.496795,"twenty":-10.059306,"median":-3.629041,"eighty":19.972394,"marketCap":3173705183},{"date":"2024-06-21","current":33.832955,"twenty":-10.062143,"median":-3.632324,"eighty":20.117746,"marketCap":3112631892},{"date":"2024-06-28","current":34.061866,"twenty":-10.071657,"median":-3.634664,"eighty":20.170141,"marketCap":3133691648},{"date":"2024-07-05","current":33.398026,"twenty":-10.071657,"median":-3.634664,"eighty":20.359437,"marketCap":3072618356},{"date":"2024-07-12","current":32.779968,"twenty":-10.071657,"median":-3.634664,"eighty":20.997672,"marketCap":3015757016},{"date":"2024-07-15","current":33.466699,"twenty":-10.071657,"median":-3.634664,"eighty":21.055774,"marketCap":3078936283},{"date":"2024-08-02","current":10.070358,"twenty":-10.150883,"median":-3.673418,"eighty":21.36338,"marketCap":3081529526},{"date":"2024-08-09","current":9.455895,"twenty":-10.150883,"median":-3.673418,"eighty":21.36338,"marketCap":2893503995},{"date":"2024-08-16","current":9.763127,"twenty":-10.150883,"median":-3.673418,"eighty":21.36338,"marketCap":2987516760},{"date":"2024-08-23","current":10.179596,"twenty":-10.150883,"median":-3.673418,"eighty":21.36338,"marketCap":3114956286},{"date":"2024-08-30","current":10.309316,"twenty":-10.150883,"median":-3.673418,"eighty":21.36338,"marketCap":3154650565},{"date":"2024-09-06","current":9.742645,"twenty":-10.150883,"median":-3.673418,"eighty":21.36338,"marketCap":2981249243},{"date":"2024-09-13","current":9.408104,"twenty":-10.150883,"median":-3.673418,"eighty":21.36338,"marketCap":2878879787},{"date":"2024-09-20","current":10.718957,"twenty":-10.150883,"median":-3.673418,"eighty":21.101408,"marketCap":3280000919},{"date":"2024-09-27","current":10.084013,"twenty":-10.150883,"median":-3.673418,"eighty":20.560563,"marketCap":3085707871},{"date":"2024-10-04","current":9.585615,"twenty":-10.150883,"median":-3.673418,"eighty":20.205634,"marketCap":2933198274},{"date":"2024-10-11","current":9.756299,"twenty":-10.150883,"median":-3.673418,"eighty":20.146479,"marketCap":2985427588},{"date":"2024-10-18","current":9.626579,"twenty":-10.150883,"median":-3.673418,"eighty":20.146479,"marketCap":2945733309},{"date":"2024-10-25","current":9.462723,"twenty":-10.150883,"median":-3.673418,"eighty":20.138028,"marketCap":2895593168},{"date":"2024-10-31","current":8.714822,"twenty":-10.150883,"median":-3.673418,"eighty":19.647887,"marketCap":2902035670},{"date":"2024-11-08","current":9.117754,"twenty":-10.153746,"median":-3.674208,"eighty":19.166669,"marketCap":3036211945},{"date":"2024-11-15","current":9.111555,"twenty":-10.153746,"median":-3.674208,"eighty":18.78122,"marketCap":3034147899},{"date":"2024-11-22","current":9.099159,"twenty":-10.153746,"median":-3.674208,"eighty":16.930479,"marketCap":3030019806},{"date":"2024-11-29","current":9.638414,"twenty":-10.153746,"median":-3.674208,"eighty":16.766106,"marketCap":3209591825},{"date":"2024-12-06","current":9.756182,"twenty":-10.153746,"median":-3.674208,"eighty":16.574337,"marketCap":3248808703},{"date":"2024-12-13","current":9.53924,"twenty":-10.153746,"median":-3.674208,"eighty":16.377088,"marketCap":3176567086},{"date":"2024-12-20","current":8.968994,"twenty":-10.153746,"median":-3.674208,"eighty":16.1771,"marketCap":2986674836},{"date":"2024-12-27","current":9.334695,"twenty":-10.153746,"median":-3.674208,"eighty":15.960675,"marketCap":3108453562},{"date":"2025-01-03","current":8.541308,"twenty":-10.153746,"median":-3.674208,"eighty":15.74151,"marketCap":2844255649},{"date":"2025-01-10","current":8.398747,"twenty":-10.15661,"median":-3.674999,"eighty":15.187166,"marketCap":2796782587},{"date":"2025-01-17","current":8.429738,"twenty":-10.15661,"median":-3.674999,"eighty":14.123802,"marketCap":2807102818},{"date":"2025-01-24","current":8.541308,"twenty":-10.15661,"median":-3.674999,"eighty":12.229294,"marketCap":2844255649},{"date":"2025-01-31","current":8.355358,"twenty":-10.15661,"median":-3.674999,"eighty":11.774076,"marketCap":2782334264},{"date":"2025-02-07","current":8.175606,"twenty":-10.15661,"median":-3.674999,"eighty":11.669683,"marketCap":2722476924},{"date":"2025-02-14","current":7.915276,"twenty":-10.15661,"median":-3.674999,"eighty":11.541332,"marketCap":2635786984},{"date":"2025-02-21","current":12.449378,"twenty":-10.15661,"median":-3.674999,"eighty":11.52593,"marketCap":2639268117},{"date":"2025-02-28","current":11.712888,"twenty":-10.15661,"median":-3.674999,"eighty":11.52593,"marketCap":2483132177},{"date":"2025-03-07","current":11.32214,"twenty":-10.159473,"median":-3.675279,"eighty":11.440344,"marketCap":2400293756},{"date":"2025-03-14","current":10.388159,"twenty":-10.159473,"median":-3.675279,"eighty":11.489992,"marketCap":2202289726},{"date":"2025-03-21","current":11.045758,"twenty":-10.159473,"median":-3.675279,"eighty":11.489992,"marketCap":2341700727},{"date":"2025-03-28","current":10.62642,"twenty":-10.159473,"median":-3.675279,"eighty":11.489992,"marketCap":2252800958},{"date":"2025-04-04","current":9.263569,"twenty":-10.159473,"median":-3.675279,"eighty":11.489992,"marketCap":1963876709},{"date":"2025-04-11","current":8.979147,"twenty":-10.15661,"median":-3.674999,"eighty":11.484858,"marketCap":1903579170},{"date":"2025-04-17","current":9.09341,"twenty":-10.15661,"median":-3.674999,"eighty":11.484858,"marketCap":1927802871},{"date":"2025-04-25","current":9.512373,"twenty":-10.159473,"median":-3.675279,"eighty":11.489992,"marketCap":2016623108},{"date":"2025-05-02","current":9.559983,"twenty":-10.159473,"median":-3.675279,"eighty":11.489992,"marketCap":2026716317},{"date":"2025-05-09","current":16.384875,"twenty":-10.159473,"median":-3.675279,"eighty":11.531064,"marketCap":2080879082},{"date":"2025-05-16","current":17.045936,"twenty":-10.159473,"median":-3.674208,"eighty":11.65257,"marketCap":2164833858},{"date":"2025-05-23","current":16.148781,"twenty":-10.159473,"median":-3.6534,"eighty":11.72393,"marketCap":2050895233},{"date":"2025-05-30","current":16.510791,"twenty":-10.159473,"median":-3.629041,"eighty":11.766258,"marketCap":2096870468},{"date":"2025-06-06","current":15.771032,"twenty":-10.159473,"median":-3.604398,"eighty":11.937378,"marketCap":2002921076},{"date":"2025-06-13","current":16.447833,"twenty":-10.159473,"median":-3.588007,"eighty":12.388042,"marketCap":2088874775},{"date":"2025-06-20","current":16.038604,"twenty":-10.162337,"median":-3.578159,"eighty":15.511387,"marketCap":2036902771},{"date":"2025-06-27","current":16.55801,"twenty":-10.162337,"median":-3.568226,"eighty":15.739397,"marketCap":2102867237},{"date":"2025-07-03","current":17.061675,"twenty":-10.162337,"median":-3.549185,"eighty":15.841236,"marketCap":2166832781},{"date":"2025-07-11","current":17.848653,"twenty":-10.162337,"median":-3.540618,"eighty":16.000829,"marketCap":2266778942},{"date":"2025-07-18","current":16.998717,"twenty":-10.162337,"median":-3.507581,"eighty":16.081216,"marketCap":2158837088},{"date":"2025-07-25","current":17.518122,"twenty":-10.162337,"median":-3.495637,"eighty":16.142485,"marketCap":2224801554},{"date":"2025-08-01","current":36.742661,"twenty":-10.162337,"median":-3.456698,"eighty":16.1771,"marketCap":2131074349},{"date":"2025-08-08","current":35.570815,"twenty":-10.162337,"median":-3.417502,"eighty":16.307701,"marketCap":2063107278},{"date":"2025-08-15","current":38.224839,"twenty":-10.162337,"median":-3.417502,"eighty":16.351669,"marketCap":2217040670},{"date":"2025-08-22","current":38.500582,"twenty":-10.162337,"median":-3.417502,"eighty":16.434619,"marketCap":2233033750},{"date":"2025-08-29","current":40.534185,"twenty":-10.162337,"median":-3.417502,"eighty":16.560113,"marketCap":2350982712},{"date":"2025-09-05","current":41.740559,"twenty":-10.1652,"median":-3.433,"eighty":16.629128,"marketCap":2420952436},{"date":"2025-09-12","current":41.361413,"twenty":-10.162337,"median":-3.417502,"eighty":16.709109,"marketCap":2398961952},{"date":"2025-09-19","current":41.809495,"twenty":-10.162337,"median":-3.417502,"eighty":16.776195,"marketCap":2424950706},{"date":"2025-09-26","current":38.914196,"twenty":-10.162337,"median":-3.417502,"eighty":16.947295,"marketCap":2257023369},{"date":"2025-10-03","current":38.224839,"twenty":-10.162337,"median":-3.417502,"eighty":17.03964,"marketCap":2217040670},{"date":"2025-10-10","current":37.052932,"twenty":-10.162337,"median":-3.417502,"eighty":17.090583,"marketCap":2149070082},{"date":"2025-10-17","current":37.501014,"twenty":-10.162337,"median":-3.417502,"eighty":17.354431,"marketCap":2175058836},{"date":"2025-10-24","current":38.466114,"twenty":-10.162337,"median":-3.417502,"eighty":17.59682,"marketCap":2231034615},{"date":"2025-10-31","current":-178.753982,"twenty":-10.172486,"median":-3.448497,"eighty":17.810878,"marketCap":2145047787},{"date":"2025-11-07","current":-169.247209,"twenty":-10.219605,"median":-3.476395,"eighty":17.810878,"marketCap":2030966504},{"date":"2025-11-14","current":-174.244666,"twenty":-10.301936,"median":-3.504298,"eighty":17.810878,"marketCap":2090935987},{"date":"2025-11-21","current":-163.916588,"twenty":-10.6072,"median":-3.538772,"eighty":17.810878,"marketCap":1966999055},{"date":"2025-11-28","current":-180.408196,"twenty":-10.799451,"median":-3.540618,"eighty":17.810878,"marketCap":2164898350},{"date":"2025-12-05","current":-174.577829,"twenty":-11.1402,"median":-3.542049,"eighty":17.810878,"marketCap":2094933953},{"date":"2025-12-12","current":-179.90845,"twenty":-11.860354,"median":-3.542049,"eighty":17.810878,"marketCap":2158901402},{"date":"2025-12-19","current":-180.574778,"twenty":-12.666412,"median":-3.542049,"eighty":17.810878,"marketCap":2166897333},{"date":"2025-12-26","current":-181.074523,"twenty":-12.945597,"median":-3.542049,"eighty":17.810878,"marketCap":2172894281},{"date":"2026-01-02","current":-174.244666,"twenty":-13.160355,"median":-3.542049,"eighty":17.810878,"marketCap":2090935987},{"date":"2026-01-09","current":-185.738817,"twenty":-13.430949,"median":-3.542049,"eighty":17.810878,"marketCap":2228865799},{"date":"2026-01-16","current":-191.402601,"twenty":-13.900553,"median":-3.542049,"eighty":17.810878,"marketCap":2296831214},{"date":"2026-01-23","current":-193.06842,"twenty":-36.411218,"median":-3.542049,"eighty":17.810878,"marketCap":2316821042},{"date":"2026-01-30","current":-181.574269,"twenty":-42.996332,"median":-3.544901,"eighty":17.810878,"marketCap":2178891230},{"date":"2026-02-06","current":-186.07198,"twenty":-44.121622,"median":-3.546973,"eighty":17.810878,"marketCap":2232863765},{"date":"2026-02-13","current":-190.236528,"twenty":-45.253331,"median":-3.546973,"eighty":17.810878,"marketCap":2282838334},{"date":"2026-02-20","current":-190.236528,"twenty":-46.332575,"median":-3.546973,"eighty":17.810878,"marketCap":2282838334},{"date":"2026-02-27","current":-8.333483,"twenty":-46.332575,"median":-3.566587,"eighty":17.810878,"marketCap":2358375720},{"date":"2026-03-06","current":-8.041704,"twenty":-46.332575,"median":-3.581442,"eighty":17.810878,"marketCap":2275802360},{"date":"2026-03-13","current":-7.379865,"twenty":-46.332575,"median":-3.589648,"eighty":17.810878,"marketCap":2088501812},{"date":"2026-03-20","current":-7.481341,"twenty":-46.332575,"median":-3.589648,"eighty":17.810878,"marketCap":2117219505},{"date":"2026-03-24","current":-7.424449,"twenty":-46.332575,"median":-3.597855,"eighty":17.810878,"marketCap":2101118977}],"updateTime":1774497680559},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PK\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2582373218","title":"Press Release: Gain Therapeutics Reports Financial Results for Third Quarter 2025 and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2582373218","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582373218?lang=en_us&edition=fundamental","pubTime":"2025-11-12 20:00","pubTimestamp":1762948800,"startTime":"0","endTime":"0","summary":"Presented initial data from Phase 1b study suggesting GT-02287 has a disease-slowing effect consistent with the preclinical models in vivo and the proposed mechanism of action. Completed enrollment of 21 participants in Phase 1b study evaluating GT-02287 in Parkinson's Disease with or without GBA1 mutations during 3Q 2025. Received approval from the Australian health authorities to extend the duration of the Phase 1b study, allowing participants to continue treatment with GT-02287 for a total of 12 months; with a majority of subjects electing to participate in the study extension. Analysis of functional changes and biomarker activity at 90 days expected to be available during 4Q 2025. Recent data presented at the International Congress of Parkinson's Disease and Movement Disorders demonstrated improvement in MDS-UPDRS scores after 90 days of dosing in the first nine pa","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GANX","R","GT","BK4181","BK4119","LU1169590202.USD","BK4022","BK4232","BK4218","PD","PK","LU1169589451.USD","BK4023","BK4139","BK4585","BK4588"],"gpt_icon":0},{"id":"2582132306","title":"EirGenix Signed The Commercial Licensinse Agreement for It's Second HER2 Biosimilar Asset EG1206A","url":"https://stock-news.laohu8.com/highlight/detail?id=2582132306","media":"prnewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582132306?lang=en_us&edition=fundamental","pubTime":"2025-11-12 16:12","pubTimestamp":1762935120,"startTime":"0","endTime":"0","summary":"EG1206A has completed its pharmacokinetic  clinical study, and last month received positive feedback from both the U.S. FDA and the European Medicines Agency , confirming that the product qualifies for an abbreviated development pathway, allowing for the waiver of Phase III comparative efficacy trials. This agreement marks another major milestone and breakthrough in EirGenix's biosimilar development efforts. This partnership further strengthens the existing collaboration between Sandoz and EirGenix. The two companies previously signed a global commercialization agreement for EG12014 . EG12014 has already been approved by the European Commission and is currently under BLA review by the U.S. FDA.Sandoz is the global leader in affordable medicines, with a growth strategy driven by its Purpose: pioneering access for patients. More than 20,000 people of 100 nationalities work together to ensure 900 million patient treatments are provided by Sandoz, generating substantial global healthcare s","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/eirgenix-signed-the-commercial-licensinse-agreement-for-its-second-her2-biosimilar-asset-eg1206a-302612768.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PK","SDZNY","BK4081","BK4181","BK4218","EMA","BK4007"],"gpt_icon":0},{"id":"2582537293","title":"Shield Therapeutics to Present Pediatric PK Results at ASH Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2582537293","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582537293?lang=en_us&edition=fundamental","pubTime":"2025-11-11 15:39","pubTimestamp":1762846753,"startTime":"0","endTime":"0","summary":"Shield Therapeutics ( ($GB:STX) ) has provided an announcement. Shield Therapeutics announced the presentation of pediatric pharmacokinetic results...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/shield-therapeutics-to-present-pediatric-pk-results-at-ash-conference?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/shield-therapeutics-to-present-pediatric-pk-results-at-ash-conference?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4109","BK4539","ASH","PK","LENZ","BK4181","LU2463526074.USD","BK4139","BK4218","BK4007"],"gpt_icon":0},{"id":"2582638391","title":"Annexon Reports Third Quarter 2025 Financial Results, Portfolio Progress and Key Anticipated Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2582638391","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582638391?lang=en_us&edition=fundamental","pubTime":"2025-11-11 05:05","pubTimestamp":1762808700,"startTime":"0","endTime":"0","summary":"Late-Stage Neuroinflammation Platform Advancing Global Registrational Programs inGuillain-Barré Syndrome (GBS) and Geographic Atrophy (GA) Current Tanruprubart GBS Dossier On Track for MAA Filing in J","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/10/3185058/0/en/Annexon-Reports-Third-Quarter-2025-Financial-Results-Portfolio-Progress-and-Key-Anticipated-Milestones.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2458330243.SGD","SOC","LU1880398471.USD","LU1861558580.USD","LU0889565833.HKD","PD","IE0004445239.USD","LU1880398554.USD","LU2458330169.SGD","BK4097","LU1852331112.SGD","BK4512","BK4529","LU0823421333.USD","BK4534","BK4218","BK4575","LU0823421416.USD","LU0823434740.USD","LU1064131342.USD","GFS","BK4139","BK4566","LU2054465674.USD","MAA","LU0823434583.USD","LU1303367103.USD","IE00B5949003.HKD","GBSG","LU1988902786.USD","PK","LU0642271901.SGD","LU1951198990.SGD","BK4554","BK4585","LU0390134368.USD","LU2250418816.HKD","BK4543","BK4141","ANNX","LU1169590202.USD","EMA","BK4532","LU0056508442.USD","PRGS","LU2098885051.SGD","LU1316542783.SGD","LU0109392836.USD","LU1242518857.USD"],"gpt_icon":1},{"id":"2581683886","title":"Immunocore presents Phase 1 data for hepatitis B candidate at AASLD’s The Liver Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2581683886","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581683886?lang=en_us&edition=fundamental","pubTime":"2025-11-07 21:00","pubTimestamp":1762520400,"startTime":"0","endTime":"0","summary":"Single ascending dose data show IMC-I109V has manageable safety profile and antiviral activity IMC-I109V is a bispecific T cell receptor targeting a peptide derived from HBsAg that is presented by HLA","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/07/3183593/0/en/Immunocore-presents-Phase-1-data-for-hepatitis-B-candidate-at-AASLD-s-The-Liver-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4181","LU1169589451.USD","LU1878469433.USD","PD","PK","BK4599","ALT","BK4139","BK4218","BK4023","LU1169590202.USD"],"gpt_icon":0},{"id":"2581439093","title":"Press Release: Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2581439093","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581439093?lang=en_us&edition=fundamental","pubTime":"2025-11-06 21:00","pubTimestamp":1762434000,"startTime":"0","endTime":"0","summary":"SALT LAKE CITY, Nov. 6, 2025 /PRNewswire/ -- Lipocine Inc. , a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery, today announced financial results for the third quarter ended September 30, 2025 and provided a corporate update.-- LPCN 1154  is a non-invasive, rapid onset, oral. formulation of the neuroactive steroid brexanolone that Lipocine is. -- A Phase 3 safety and efficacy study evaluating LPCN 1154 as a treatment. for PPD continues to enroll patients and top-line data is expected in the. second quarter of 2026. A meeting of the independent Data Safety. Monitoring Board  overseeing this trial will take place to review. safety data from the first one-third of participants who were randomized. and completed the day seven follow up visit, and the Company plans to. provide a safety update in November 2025 following the DSMB review.-- Lipocine believes data from the Phase 3 study will be beneficial for. pote","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4530","BK4105","BK4563","BK4218","PPD","LPCN","BK4588","PK","LU1093756325.SGD","BK4181","TM","PAM","BK4099","IE00B19Z3581.USD","LU0061475181.USD","BK4555","03160","BK4007","LU1093756168.USD","BK4561","IE00B19Z3B42.SGD","BK4081","ASM","DRE","BK4188","AES","BK4604","IE0002270589.USD","BK4171","BK4585","BK4121","BK4519","IE00B7SZLL34.SGD"],"gpt_icon":0},{"id":"2581235095","title":"Erasca Announces Issuance of a U.S. Patent Covering Pan-RAS Molecular Glue ERAS-0015","url":"https://stock-news.laohu8.com/highlight/detail?id=2581235095","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581235095?lang=en_us&edition=fundamental","pubTime":"2025-11-06 21:00","pubTimestamp":1762434000,"startTime":"0","endTime":"0","summary":"The issued patent provides intellectual property protection for ERAS-0015 and related compositions until at least 2043 Initial Phase 1 monotherapy data for ERAS-0015 and pan-KRAS inhibitor ERAS-4001 e","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/06/3182529/0/en/Erasca-Announces-Issuance-of-a-U-S-Patent-Covering-Pan-RAS-Molecular-Glue-ERAS-0015.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","PK","ADME","BK4181","ERAS","BK4139","BK4218"],"gpt_icon":0},{"id":"2581721670","title":"Press Release: Sionna Therapeutics Reports Third Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2581721670","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581721670?lang=en_us&edition=fundamental","pubTime":"2025-11-05 20:00","pubTimestamp":1762344000,"startTime":"0","endTime":"0","summary":"Initiated PreciSION CF Phase 2a proof-of-concept trial evaluating NBD1 stabilizer SION-719 as an add-on to standard of care in participants with cystic fibrosis. Successfully completed drug-drug interaction study to support initiation of PreciSION CF Phase 2a. Initiated Phase 1 trial evaluating NBD1 stabilizer SION-451 in proprietary dual combinations with SION-2222 and with SION-109 in healthy volunteers. Topline data from both trials anticipated in mid-2026. Maintained strong cash position with approximately $325.0 million in cash and cash equivalents, expected to fund operations into 2028. WALTHAM, Mass., Nov. 05, 2025  -- Sionna Therapeutics, Inc. , a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis  by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator  protein, today reported financial results for the quarter ended September 30, 2025, and provide","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PK","BK4213","SION","SOC","BK4181","CF","BK4022","BK4218","R","BK4139","BK4585","BK4232","BK4093","BK4588"],"gpt_icon":0},{"id":"2581274722","title":"Centessa Pharmaceuticals Reports Financial Results for the Third Quarter of 2025 and Provides Update on Potential Best-in-Class Orexin Receptor 2 (OX2R) Agonist Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2581274722","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581274722?lang=en_us&edition=fundamental","pubTime":"2025-11-05 20:00","pubTimestamp":1762344000,"startTime":"0","endTime":"0","summary":"ORX750: Demonstrated potential best-in-class profile for treatment of narcolepsy type 1 (NT1), narcolepsy type 2 (NT2), and idiopathic hypersomnia (IH) in initial cohorts of ongoing Phase 2a study; Da","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/05/3181265/0/en/Centessa-Pharmaceuticals-Reports-Financial-Results-for-the-Third-Quarter-of-2025-and-Provides-Update-on-Potential-Best-in-Class-Orexin-Receptor-2-OX2R-Agonist-Program.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4215","BK4585","BK4181","IH","BK4023","BK4085","LU1169589451.USD","BK4563","PD","ESS","PK","BK4510","BK4218","BK4588","LU1169590202.USD","BK4597"],"gpt_icon":0},{"id":"2581769640","title":"Avadel Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2581769640","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581769640?lang=en_us&edition=fundamental","pubTime":"2025-11-05 05:01","pubTimestamp":1762290060,"startTime":"0","endTime":"0","summary":"– Generated LUMRYZ net product revenue of $77.5 million, a 55% increase compared to third quarter 2024 – – Approximately 3,400 patients on LUMRYZ as of September 30, 2025, a 48% increase compared to S","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/04/3180824/0/en/Avadel-Pharmaceuticals-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Corporate-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4181","BK4588","CNS","BK4215","CVR","PK","BK4597","ESS","BK4135","BK4585","BK4161","BK4218"],"gpt_icon":0},{"id":"2580734175","title":"Certara Automates Scientific Workflows with Phoenix® Cloud","url":"https://stock-news.laohu8.com/highlight/detail?id=2580734175","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580734175?lang=en_us&edition=fundamental","pubTime":"2025-11-04 21:00","pubTimestamp":1762261200,"startTime":"0","endTime":"0","summary":"New cloud capabilities cut time to create Tables, Figures, and Listings by 50%RADNOR, Pa., Nov.  04, 2025  (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug deve","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/04/3180251/0/en/Certara-Automates-Scientific-Workflows-with-Phoenix-Cloud.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4218","LU1169589451.USD","PK","BK4167","LU1169590202.USD","PD","BK4181","BK4023","CERT"],"gpt_icon":0},{"id":"2580735300","title":"Tonix Pharmaceuticals Announces Collaboration with Massachusetts General Hospital to Advance Phase 2 Clinical Trial of Dimeric Fc-modified anti-CD40L mAb, TNX-1500, to Prevent Kidney Transplant Organ Rejection","url":"https://stock-news.laohu8.com/highlight/detail?id=2580735300","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580735300?lang=en_us&edition=fundamental","pubTime":"2025-11-04 20:00","pubTimestamp":1762257600,"startTime":"0","endTime":"0","summary":"Planning to initiate an open-label Phase 2 study of TNX-1500 under an investigator-initiated IND to evaluate safety and activity in the first half of 2026 Novel immunomodulatory regimen designed to re","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/04/3180117/28908/en/Tonix-Pharmaceuticals-Announces-Collaboration-with-Massachusetts-General-Hospital-to-Advance-Phase-2-Clinical-Trial-of-Dimeric-Fc-modified-anti-CD40L-mAb-TNX-1500-to-Prevent-Kidney.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HI","PD","LU0128526141.USD","BK4023","BK4139","LU2360032135.SGD","BK4181","BK4218","LU1169589451.USD","LU2125154778.USD","LU0029874061.USD","LU2125154935.USD","TNXP","BK4135","PK","LU1169590202.USD","BK4161","BK4583","CNS"],"gpt_icon":0},{"id":"2580228110","title":"ProMIS Neurosciences to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2580228110","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580228110?lang=en_us&edition=fundamental","pubTime":"2025-11-04 05:05","pubTimestamp":1762203900,"startTime":"0","endTime":"0","summary":"Cambridge, Massachusetts, Nov.  03, 2025  (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing next-generation therapies for Alzheimer’s dise","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/03/3179794/0/en/ProMIS-Neurosciences-to-Participate-in-the-Guggenheim-2nd-Annual-Healthcare-Innovation-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARIA","LU0029874061.USD","BK4218","BK4588","PK","LU2211815571.USD","BK4181","LU1169590202.USD","MSA","PD","BK4581","LU0757428866.USD","BK4137","LU0128526141.USD","XLV","LU1815336091.USD","LABU","LU2125909759.SGD","BK4526","BK4600","LU2125909916.SGD","LU0053671581.USD","BK4023","AD","LU0728928796.USD","BK4170","BK4132","BK4595","LU1923622291.USD","BK4585","LU1169589451.USD","USA","XBI","BK4143","HCSG"],"gpt_icon":1},{"id":"2580191222","title":"B. Riley Adjusts Price Target on PK International to $16 From $12.50, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2580191222","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580191222?lang=en_us&edition=fundamental","pubTime":"2025-11-03 22:08","pubTimestamp":1762178913,"startTime":"0","endTime":"0","summary":"B. Riley Adjusts Price Target on PK International to $16 From $12.50, Maintains Buy Rating","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PK","RILY"],"gpt_icon":0},{"id":"2580219131","title":"Agios to Present New Mitapivat Data in Rare Blood Disorders at 67th ASH Annual Meeting and Exposition","url":"https://stock-news.laohu8.com/highlight/detail?id=2580219131","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580219131?lang=en_us&edition=fundamental","pubTime":"2025-11-03 22:01","pubTimestamp":1762178460,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., Nov.  03, 2025  (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company focused on delivering innovative medicines for patients w","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/03/3179391/31990/en/Agios-to-Present-New-Mitapivat-Data-in-Rare-Blood-Disorders-at-67th-ASH-Annual-Meeting-and-Exposition.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PK","ASH","BK4181","SCD","LU2463526074.USD","BK4218","BK4109"],"gpt_icon":0},{"id":"1107239871","title":"Which App is Best for Tracking Gold Prices? Ultimate Comparison of Three Platforms – This One is Favored by Gold Investors!","url":"https://stock-news.laohu8.com/highlight/detail?id=1107239871","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107239871?lang=en_us&edition=fundamental","pubTime":"2025-11-03 16:41","pubTimestamp":1762159290,"startTime":"0","endTime":"0","summary":"Hot Topics Custom Stocks   Data Center   Market Center   Capital Flows   Simulated Trading Client When trading gold, choosing the right app is crucial. With numerous options available, making a...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QOmain","BK4181","NUGT","518880","159934","DUST","GLD","BK4218","PK","GCmain","1OZmain","GDX","159831","SGUmain","SGCmain","IAU","MGCmain"],"gpt_icon":1},{"id":"2579495402","title":"Evercore ISI Keeps Their Hold Rating on Park Hotels & Resorts (PK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2579495402","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579495402?lang=en_us&edition=fundamental","pubTime":"2025-10-31 22:57","pubTimestamp":1761922657,"startTime":"0","endTime":"0","summary":"Evercore ISI analyst Duane Pfennigwerth maintained a Hold rating on Park Hotels & Resorts today and set a price target of $13.00. The company’s sha...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/evercore-isi-keeps-their-hold-rating-on-park-hotels-resorts-pk-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/evercore-isi-keeps-their-hold-rating-on-park-hotels-resorts-pk-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PK"],"gpt_icon":0},{"id":"2579310633","title":"Park Hotels & Resorts Inc reports results for the quarter ended September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2579310633","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579310633?lang=en_us&edition=fundamental","pubTime":"2025-10-31 05:59","pubTimestamp":1761861544,"startTime":"0","endTime":"0","summary":"Park Hotels & Resorts Inc reports results for the quarter ended September 30 - Earnings SummaryPark Hotels & Resorts Inc PK.N reported a quarterly adjusted loss of 8 cents per share for the quarter en","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nL8N3WB3YI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4181","BK4218","PK"],"gpt_icon":0},{"id":"2579174759","title":"Park Hotels & Resorts posts $14 million net loss in Q3 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2579174759","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579174759?lang=en_us&edition=fundamental","pubTime":"2025-10-31 04:13","pubTimestamp":1761855220,"startTime":"0","endTime":"0","summary":"Park Hotels & Resorts Inc. reported a comparable RevPAR of $180.9 for the third quarter of 2025, representing a decrease of 6.1% compared to the same period in 2024, or a 4.9% decrease when excluding the Royal Palm South Beach Miami, which suspended operations in mid-May 2025 for renovation. The company recorded a net loss of $14 million and a net loss attributable to stockholders of $16 million. Adjusted EBITDA was $130 million. Diluted loss per share was $0.08, and diluted Adjusted FFO per share was $0.35. During the quarter, Park increased its liquidity to $2.1 billion to address maturing loans and continued to reshape its portfolio through non-core asset dispositions, including the permanent closure of the Embassy Suites Kansas City Plaza at the end of September. The company also invested in ongoing renovations at its Hawaii resorts, the Hilton New Orleans Riverside, and the Royal Palm in Miami. The decrease in comparable RevPAR was attributed to softer leisure and government trans","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nNDL1vMlb8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4181","BK4218","PK"],"gpt_icon":0},{"id":"2579742041","title":"BRIEF-Park Hotels & Resorts Q3 Adjusted FFO Per Share USD 0.35","url":"https://stock-news.laohu8.com/highlight/detail?id=2579742041","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579742041?lang=en_us&edition=fundamental","pubTime":"2025-10-31 04:10","pubTimestamp":1761855046,"startTime":"0","endTime":"0","summary":"BRIEF-Park Hotels & Resorts Q3 Adjusted FFO Per Share USD 0.35\n\n\nOct 30 (Reuters) - Park Hotels & Resorts Q3 adjusted revpar USD 180.93.\n\nQ3 EPS USD -0.08\nQ3 net income USD -14 million","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nPLX2654EC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4181","BK4218","PK"],"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":7,"totalSize":172,"code":"91000000","status":"200"}]}}